A Preliminary, Open-Label Study of Naltrexone and Bupropion Combination Therapy for Treating Binge Drinking in Human Subjects.

Aims The combination of bupropion and naltrexone has shown efficacy in reducing binge drinking in animal models. This study assessed the tolerability and potential utility of combined naltrexone and bupropion in reducing binge drinking in human subjects. Methods This preliminary study employed an op...

Descripción completa

Detalles Bibliográficos
Publicado en:Alcohol & Alcoholism Vol. 55; no. 1; pp. 56 - 63
Autores principales: Walter, T Jordan, Navarro, Montserrat, Thiele, Todd E, Pedersen, Cort, Kampov-Polevoy, Alexey, Garbutt, J C
Formato: clinical trial research tables/charts Journal Article
Publicado: Oxford University Press / USA Jan2020
Acceso en línea:Ver este registro en EBSCOhost